Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ABBV-637
i
Other names:
ABBV-637, ABBV 637
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
AbbVie
Drug class:
EGFR-targeted antibody-drug conjugate, Bcl-xL inhibitor
Related drugs:
‹
HTI-1511 (7)
DM001 (6)
MRG003 (6)
ABBV-321 (6)
LR004-VC-MMAE (5)
SHR-A1307 (4)
M1231 (3)
ABT-414 (3)
BB-1705 (2)
DM005 (2)
ABBV-221 (2)
AZD9592 (2)
BL-B01D1 (1)
AVID100 (0)
CPO301 (0)
IMGN289 (0)
ABT 263 (19)
APG-1252 (8)
A-1331852 (6)
APG1244 (2)
AT 101 (1)
AZD0466 (0)
AZD4320 (0)
LP-118 (0)
ABBV-155 (0)
ONT-701 (0)
HTI-1511 (7)
DM001 (6)
MRG003 (6)
ABBV-321 (6)
LR004-VC-MMAE (5)
SHR-A1307 (4)
M1231 (3)
ABT-414 (3)
BB-1705 (2)
DM005 (2)
ABBV-221 (2)
AZD9592 (2)
BL-B01D1 (1)
AVID100 (0)
CPO301 (0)
IMGN289 (0)
ABT 263 (19)
APG-1252 (8)
A-1331852 (6)
APG1244 (2)
AT 101 (1)
AZD0466 (0)
AZD4320 (0)
LP-118 (0)
ABBV-155 (0)
ONT-701 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login